Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain

• Status: Completed
• Trial end date: 2019-01-15
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with Acute low back pain

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Navipharm Corporation

Criteria

Inclusion Criteria:

• Subjects who have ability to comprehend the contents of study and before participating in trial and have willingness to sign of informed consent in writing

• 19 Years and older

• A patient has symptom of acute low back pain

Exclusion Criteria:

• Subjects who cannot prohibit anti-inflammatory drug or muscle relaxants during clinical trial

• Inadequate subject for the clinical trial by the investigator's decision